Orexigen Therapeutics to Present at Upcoming Conferences

  //health-fitness.news-articles.net/content/2012/ .. apeutics-to-present-at-upcoming-conferences.html
  Published in Health and Fitness on Thursday, February 9th 2012 at 5:11 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Orexigen Therapeutics to Present at Upcoming Conferences -- SAN DIEGO, Feb. 9, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about OREX

SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Orexigen^® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will be presenting at two upcoming investor conferences.  The details are as follows:

The 14th Annual BIO CEO & Investor Conference
Date:  February 13, 2012
Time:  1:30pm Eastern Time
Location:  Waldorf Astoria, New York
Speaker:  Michael Narachi, President and Chief Executive Officer

Leerink Swann Global Healthcare Conference
Date:  February 15, 2012
Time:  8:00am Eastern Time
Location:  Waldorf Astoria, New York
Speaker:  Michael Narachi, President and Chief Executive Officer

To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the company's Web site at [ www.orexigen.com ]. A replay will be available for 14 days after the event.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave^® has completed Phase 3 clinical trials for which a New Drug Application has been submitted and reviewed by the FDA, and the FDA has agreed to a SPA for the Contrave outcomes trial.  The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

SOURCE Orexigen Therapeutics, Inc.

RELATED LINKS
[ http://www.orexigen.com ]